Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors
New pyridazin-e-(2H)-one derivatives having the chemical structure of general formula (I) are disclosed; as well as processes for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of phosphodiesterase 4.
1. A pyridazinone derivative of formula (I)
wherein
R 1 represents:
a hydrogen atom;
a group chosen from acyl, alkoxycarbonyl, carbamoyl, monoalkylcarbamoyl and dialkylcarbamoyl;
an alkyl, alkenyl or alkynyl group, wherein the alkyl, alkenyl or alkynyl group is optionally substituted by one or more substituents chosen from halogen atoms, hydroxy, alkoxy, aryloxy, alkylthio, arylthio, oxo, amino, mono- and di-alkylamino, acylamino, hydroxycarbonyl, alkoxycarbonyl, carbamoyl and mono- and di-alkylcarbamoyl groups;
an aryl or heteroaryl group, wherein the aryl or heteroaryl group is optionally substituted by one or more substituents chosen from halogen atoms, hydroxy, hydroxyalkyl, hydroxycarbonyl, alkoxy, alkylenedioxy, alkoxycarbonyl, aryloxy, acyl, acyloxy, alkylthio, arylthio, amino, nitro, cyano, mono- and di-alkylamino, acylamino, carbamoyl, mono- and di-alkylcarbamoyl, difluoromethyl, trifluoromethyl, difluoromethoxy, and trifluoromethoxy groups;
a saturated or unsaturated heterocyclic group, wherein the saturated or unsaturated heterocyclic group is optionally substituted by one or more substituents chosen from halogen atoms, hydroxy, hydroxyalkyl, hydroxycarbonyl, alkoxy, alkylenedioxy, alkoxycarbonyl, aryloxy, acyl, acyloxy, alkylthio, arylthio, oxo, amino, nitro, cyano, mono- and di-alkylamino, acylamino, carbamoyl, mono- and di-alkylcarbamoyl, difluoromethyl, trifluoromethyl, difluoromethoxy, and trifluoromethoxy groups; or
a group of formula
—(CH 2 ) n —R 6
wherein n is an integer from 0 to 4 and R 6 represents:
a cycloalkyl or cycloalkenyl group;
an aryl group, which is optionally substituted by one or more substituents chosen from halogen atoms, alkyl, hydroxy, alkoxy, alkylenedioxy, alkylthio, amino, mono- and di-alkylamino, nitro, acyl, hydroxycarbonyl, alkoxycarbonyl, carbamoyl, mono- and di-alkylcarbamoyl, cyano, trifluoromethyl, difluoromethoxy, and trifluoromethoxy groups;
or a 3- to 7-membered ring comprising from 1 to 4 heteroatoms chosen from nitrogen, oxygen and sulphur, which ring is optionally substituted by one or more substituents chosen from halogen atoms, alkyl, hydroxy, alkoxy, alkylenedioxy, amino, mono- and di-alkylamino, nitro, cyano and trifluoromethyl groups;
R 2 represents:
a hydrogen atom;
a group chosen from acyl, alkoxycarbonyl, carbamoyl, monoalkylcarbamoyl and dialkylcarbamoyl;
an alkyl, alkenyl or alkynyl group, wherein the alkyl, alkenyl or alkynyl group is optionally substituted by one or more substituents chosen from halogen atoms, hydroxy, alkoxy, hydroxycarbonyl, alkoxycarbonyl, aryloxy, alkylthio, arylthio, oxo, amino, mono- and di-alkylamino, acylamino, carbamoyl, and mono- and di-alkylcarbamoyl groups;
an aryl or heteroaryl group, wherein the aryl or heteroaryl group is optionally substituted by one or more substituents chosen from halogen atoms, hydroxy, hydroxyalkyl, hydroxycarbonyl, alkoxy, alkylenedioxy, alkoxycarbonyl, aryloxy, acyl, acyloxy, alkylthio, arylthio, amino, nitro, cyano, mono- and di-alkylamino, acylamino, carbamoyl, mono- and di-alkylcarbamoyl, difluoromethyl, trifluoromethyl, difluoromethoxy, and trifluoromethoxy groups;
a saturated or unsaturated heterocyclic group, wherein the saturated or unsaturated heterocyclic group is optionally substituted by one or more substituents chosen from halogen atoms, hydroxy, hydroxyalkyl, hydroxycarbonyl, alkoxy, alkylenedioxy, alkoxycarbonyl, aryloxy, acyl, acyloxy, alkylthio, arylthio, oxo, amino, nitro, cyano, mono- and di-alkylamino, acylamino, carbamoyl, mono- and di-alkylcarbamoyl, difluoromethyl, trifluoromethyl, difluoromethoxy and trifluoromethoxy groups; or
a group of formula
—(CH 2 ) n —R 6
wherein n is an integer from 0 to 4 and R 6 represents:
a cycloalkyl or cycloalkenyl group;
an aryl group, which is optionally substituted by one or more substituents chosen from halogen atoms and alkyl, hydroxy, alkoxy, alkylenedioxy, alkylthio, amino, mono- and di-alkylamino, nitro, acyl, hydroxycarbonyl, alkoxycarbonyl, carbamoyl, mono- and di-alkylcarbamoyl, cyano, trifluoromethyl, difluoromethoxy, and trifluoromethoxy groups;
or a 3- to 7-membered ring comprising from 1 to 4 heteroatoms chosen from nitrogen, oxygen and sulphur, which ring is optionally substituted by one or more substituents chosen from halogen atoms, alkyl, hydroxy, alkoxy, alkylenedioxy, amino, mono- and di-alkylamino, nitro, cyano, and trifluoromethyl groups;
R 3 represents a monocyclic or polycyclic aryl or a monocyclic or polycyclic heteroaryl group, wherein the monocyclic or polycyclic aryl or the monocyclic or polycyclic heteroaryl group are optionally substituted by one or more substituents chosen from:
halogen atoms;
alkyl and alkylene groups, wherein the alkyl and alkylene groups are optionally substituted by one or more substituents chosen from halogen atoms, phenyl, hydroxy, alkoxy, aryloxy, alkylthio, arylthio, oxo, amino, mono- and di-alkylamino, acylamino, hydroxycarbonyl, alkoxycarbonyl, carbamoyl, and mono- and di-alkylcarbamoyl groups; and
phenyl, hydroxy, hydroxyalkyl, alkoxy, cycloalkoxy, nitro, cyano, aryloxy, alkylthio, arylthio, alkylsulfinyl, alkylsulfonyl, alkylsulfamoyl, acyl, amino, mono- and di-alkylamino, acylamino, hydroxycarbonyl, alkoxycarbonyl, carbamoyl, mono- and di-alkylcarbamoyl, ureido, N′-alkylureido, N′, N′-dialkylureido, alkylsulfamido, aminosulfonyl, mono- and di-alkylaminosulfonyl, difluoromethoxy, and trifluoromethoxy groups;
R 4 represents:
a hydrogen atom;
a hydroxy, alkoxy, amino, monoalkylamino, dialkylamino or cyano group;
an alkyl, alkenyl or alkynyl group, wherein the alkyl, alkenyl or alkynyl group is optionally substituted by one or more substituents chosen from halogen atoms, hydroxy, acyloxy, alkoxy, aryloxy, alkylthio, arylthio, amino, mono- and di-alkylamino, acylamino, hydroxycarbonyl, alkoxycarbonyl, alkoxyimino, carbamoyl, and mono- and di-alkylcarbamoyl groups;
or a group of formula
—(CH 2 ) n —R 6
wherein n is an integer from 0 to 4 and R 6 represents:
a cycloalkyl or cycloalkenyl group;
an aryl group, which is optionally substituted by one or more substituents chosen from halogen atoms, alkyl, hydroxy, alkoxy, alkylenedioxy, alkylthio, amino, mono- and di-alkylamino, nitro, acyl, hydroxycarbonyl, alkoxycarbonyl, carbamoyl, mono- and di-alkylcarbamoyl, cyano, trifluoromethyl, difluoromethoxy, and trifluoromethoxy groups;
or a 3- to 7-membered ring comprising from 1 to 4 heteroatoms chosen from nitrogen, oxygen and sulphur, which ring is optionally substituted by one or more substituents chosen from halogen atoms, alkyl, phenyl, alkoxyphenyl, halophenyl, pyridyl, alkoxycarbonyl, hydroxy, alkoxy, alkylenedioxy, amino, mono- and di-alkylamino, nitro, cyano, and trifluoromethyl groups;
R 5 represents a group —COOR 7 or a monocyclic or polycyclic aryl or a monocyclic or polycyclic heteroaryl group, wherein the monocyclic or polycyclic aryl or the monocyclic or polycyclic heteroaryl group are optionally substituted by one or more substituents chosen from:
halogen atoms;
alkyl and alkenyl groups, wherein the alkyl and alkenyl groups are optionally substituted by one or more substituents chosen from halogen atoms, phenyl, hydroxy, hydroxyalkyl, alkoxy, aryloxy, alkylthio, arylthio, oxo, amino, mono- and di-alkylamino, acylamino, hydroxycarbonyl, alkoxycarbonyl, carbamoyl, mono- and di-alkylcarbamoyl groups; and
phenyl, hydroxy, alkylenedioxy, alkoxy, cycloalkyloxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylsulfamoyl, amino, mono- and di-alkylamino, acylamino, nitro, acyl, hydroxycarbonyl, alkoxycarbonyl, carbamoyl, mono- and di-alkylcarbamoyl, ureido, N′-alkylureido, N′,N′-dialkylureido, alkylsulfamido, aminosulfonyl, mono- and di-alkylaminosulfonyl, cyano, difluoromethoxy, and trifluoromethoxy groups;
wherein R 7 represents
an alkyl, which is optionally substituted by one or more substituents chosen from halogen atoms, hydroxy, alkoxy, aryloxy, alkylthio, arylthio, oxo, amino, mono- and di-alkylamino, acylamino, hydroxycarbonyl, alkoxycarbonyl, carbamoyl, and mono- and di-alkylcarbamoyl groups,
or a group of formula
—(CH 2 ) n —R 6
wherein n is an integer from 0 to 4 and R 6 represents:
a cycloalkyl or cycloalkenyl group;
an aryl group, which is optionally substituted by one or mote substituents chosen from halogen atoms, alkyl, hydroxy, alkoxy, alkylenedioxy, alkylthio, amino, mono- and di-alkylamino, nitro, acyl, hydroxycarbonyl, alkoxycarbonyl, carbamoyl, mono- and di-alkylcarbamoyl, cyano, trifluoromethyl, difluoromethoxy, and trifluoromethoxy groups;
or a 3- to 7-membered ring comprising from 1 to 4 heteroatoms chosen from nitrogen, oxygen and sulphur, which ring is optionally substituted by one or more substituents chosen from halogen atoms, alkyl, phenyl, alkoxyphenyl, halophenyl, pyridyl, alkoxycarbonyl, hydroxy, alkoxy, alkylenedioxy, amino, mono- and di-alkylamino, nitro, cyano, and trifluoromethyl groups;
or a salt thereof, or a N-oxide thereof
with the proviso that when R 1 is methyl, R 2 is H, and both R 3 and R 5 are phenyl then R 4 is not a 1-hydroxyethyl group.
2. A compound according to claim 1 , wherein R 1 is chosen from hydrogen atoms and alkyl groups, wherein the alkyl groups are optionally substituted by one or more substituents chosen from halogen atoms, hydroxy, alkoxy, alkylthio, hydroxycarbonyl and alkoxycarbonyl groups.
3. A compound according to claim 2 wherein R 1 is chosen from unsubstituted C 1-4 alkyl groups.
4. A compound according to claim 1 , wherein R 2 is chosen from:
hydrogen atoms,
an acyl group,
an alkyl group, which is optionally substituted by one or more substituents chosen from halogen atoms, hydroxy, alkoxy, and alkylthio groups; and
aryl and heteroaryl groups, wherein the aryl and heteroaryl groups are optionally substituted by one or more substituents chosen from halogen atoms, hydroxy, hydroxyalkyl, hydroxycarbonyl, alkoxy, alkylenedioxy, alkoxycarbonyl, aryloxy, acyl, acyloxy, alkylthio, arylthio, amino, nitro, cyano, mono- and di-alkylamino, acyiamino, carbamoyl, mono- and di-alkylcarbamoyl, difluoromethyl, trifluoromethyl, difluoromethoxy, and trifluoromethoxy groups.
5. A compound according to claim 4 wherein R 2 is a hydrogen atom.
6. A compound according to claim 1 , wherein R 3 represents a monocyclic or polycyclic aryl or a monocyctic or polycyclic heteroaryl group, wherein the monocyclic or polycyclic, aryl or the monocyclic or polycyclic heteroaryl group are optionally substituted by one or more substituents chosen from:
halogen atoms;
alkyl and alkylene groups, wherein the alkyl and alkylene groups are optionally substituted by one or more substituents chosen from halogen atoms, phenyl, hydroxy, alkoxy, aryloxy, alkylthio, arylthio, oxo, amino, mono- or di-alkylamino, acylamino, hydroxycarbonyl, alkoxycarbonyl, carbamoyl and mono- and di-alkylcarbamoyl groups; and
phenyl, hydroxy, hydroxyalkyl, alkoxycarbonyl, alkoxy, cycloalkoxy, nitro, cyano, aryloxy, alkylthio, arylthio, alkylsuifinyl, alkylsulfonyl, alkylsulfamoyl, acyl, amino, mono- and di-alkylamino, acylamino, hydroxycarbonyl, carbamoyl, mono- and di-alkylcarbamoyl, ureido, N′-alkylureido, N′,N′-dialkylureido, alkylsulfamido, aminosulfonyl, mono- and di-alkylaminosulfonyl, difluoromethoxy, and trifluoromethoxy groups.
7. A compound according to claim 6 , wherein R 3 represents a monocyclic or polycyclic aryl or a monocyclic or polycyclic heteroaryl group, wherein the monocyclic or polycyclic, aryl or the monocyclic or polycyclic heteroaryl group are optionally substituted by one substituent chosen from halogen atoms, alkyl groups and hydroxycarbonyl groups.
8. A compound according to claim 7 , wherein R 3 represents a phenyl group or a monocyclic or polycyclic N-containing heteroaryl group, wherein the phenyl group or the monocyclic or polycyclic N-containing heteroaryl group may be substituted by one substituent chosen from halogen atoms, alkyl groups and hydroxycarbonyl groups.
9. A compound according to claim 1 , wherein R 4 represents:
a hydrogen atom;
a cyano group;
an alkyl, alkenyl or alkynyl group, wherein the alkyl, alkenyl or alkynyl group is optionally substituted by one or more substituents chosen from halogen atoms, hydroxy, acyloxy, alkoxy, aryloxy, alkylthio, arylthio, amino, mono- and di-alkylamino, acylamino, hydroxycarbonyl, alkoxycarbonyl, carbamoyl, and mono- and di-alkylcarbamoyl groups;
or a group of formula
—(CH 2 ) n —R 6
wherein n is an integer from 0 to 4 and R 6 represents a 3- to 7-membered ring comprising from 1 to 4 heteroatoms chosen from nitrogen, oxygen and sulphur, which ring is optionally substituted by one or more substituents chosen from halogen atoms, alkyl, phenyl, alkoxyphenyl, halophenyl, pyridyl, alkoxycarbonyl, hydroxy, alkoxy, alkylenedioxy, amino, mono- and di-alkylamino, nitro, cyano, and trifluoromethyl groups.
10. A compound according to claim 9 wherein R 4 represents a hydrogen atom or a cyano group.
11. A compound according to claim 1 , wherein R 5 represents a group —COOR 7 , a monocyclic or polycyclic aryl or a monocyclic or polycyclic heteroaryl group, wherein the monocyclic or polycyclic aryl or the monocyclic or polycyclic heteroaryl group are optionally substituted by one or more substituents chosen from:
halogen atoms;
alkyl groups, which are optionally substituted by one or more substituents chosen from halogen atoms, hydroxy, hydroxyalkyl, alkoxy, alkylthio, mono- or di-alkylamino, acylamino, hydroxycarbonyl, alkoxycarbonyl, carbamoyl, and mono- and di-alkylcarbamoyl groups; and
hydroxy, alkylenedioxy, alkoxy, cycloalkyloxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylsulfamoyl, amino, mono- and di-alkylamino, acylamino, nitro, acyl, hydroxycarbonyl, alkoxycarbonyl, carbamoyl, mono- and di-alkylcarbamoyl, ureido, N′-alkylureido, N′,N′-dialkylureido, alkylsulfamido, aminosuphonyl, mono- and di-alkylaminosulfonyl, cyano, difluoromethoxy, and trifluoromethoxy groups;
wherein R 7 represents
an alkyl group, which is optionally substituted by one or more substituents chosen from halogen atoms, hydroxy, alkoxy, aryloxy, alkylthio, arylthio, oxo, amino, mono- and di-alkylamino, acylamino, hydroxycarbonyl, alkoxycarbonyl, carbamoyl, and mono- and di-alkylcarbamoyl groups
or a group of formula
—(CH 2 ) n —R 6
wherein n Is an integer from 0 to 4 and R 6 represents:
a cycloalkyl or cycloalkenyl group;
an aryl group, which is optionally substituted by one or more substituents chosen from halogen atoms, alkyl, hydroxy, alkoxy, alkylenedioxy, alkylthio, amino, mono- and di-alkylamino, nitro, acyl, hydroxycarbonyl, alkoxycarbonyl, carbamoyl, mono- and di-alkylcarbamoyl, cyano, trifluorornethyl, difluoromethoxy, and trifluoromethoxy groups;
or a 3- to 7-membered ring comprising from 1 to 4 heteroatoms chosen from nitrogen, oxygen and sulphur, which ring is optionally substituted by one or more substituents chosen from halogen atoms, alkyl, phenyl, hydroxy, alkoxy, alkylenedioxy, amino, mono- and di-alkylamino, nitro, cyano, and trifluoromethyl groups.
12. A compound according to claim 11 , wherein R 5 represents a monocyclic aryl or heteroaryl group, wherein the monocyclic aryl or heteroaryl group is optionally substituted by one or more substituents chosen from halogen atoms and alkyl groups.
13. A compound according to claim 1 , wherein R 1 is chosen from hydrogen atoms and alkyl groups, which are optionally substituted by one or more substituents chosen from halogen atoms, hydroxy, alkoxy, alkylthio, arylthio, hydroxycarbonyl and alkoxycarbonyl groups; and
R 2 is chosen from:
hydrogen atoms,
an acyl group
an alkyl group, which is optionally substituted by one or more substituents chosen from halogen atoms, hydroxy, alkoxy and alkylthio groups; and
aryl and heteroaryl groups, wherein the aryl and heteroaryl groups are optionally substituted by one or more halogen atoms.
14. A compound according to claim 13 , wherein R 1 is chosen from unsubstituted C 1-4 alkyl groups and R 2 is a hydrogen atom.
15. A compound according to claim 14 , wherein R 3 represents a monocyclic or polycyclic aryl or a monocyclic or polycyclic heteroaryl group, wherein the monocyclic or polycyclic aryl or the monocyclic or polycyclic heteroaryl group are optionally substituted by one or more substituents chosen from:
halogen atoms;
alkyl groups, which are optionally substituted by one or more substituents chosen from halogen atoms and hydroxy groups; and
cyano, and hydroxycarbonyl groups.
16. A compound according to claim 15 , wherein R 3 represents a phenyl group or a monocyclic or polycyclic N-containing heteroaryl group, wherein the phenyl group or the monocyclic or polycyclic N-containing heteroaryl group may be substituted by one substituent chosen from halogen atoms, alkyl groups and hydroxycarbonyl groups.
17. A compound according to claim 13 , wherein R 4 represents:
a hydrogen atom;
a cyano group;
an alkyl, alkenyl or alkynyl group, wherein the alkyl, alkenyl or alkynyl group is optionally substituted by one or more substituents chosen from halogen atoms, hydroxyl and alkoxy groups;
or a group of formula
—(CH 2 ) n —R 6
wherein n is 0 and R 6 represents a 3- to 7-membered ring comprising from 1 to 4 heteroatoms chosen from nitrogen, oxygen and sulphur, which ring is optionally substituted by one or more substituents chosen from halogen atoms, alkyl and phenyl groups.
18. A compound according to claim 17 wherein R 4 represents a hydrogen atom or a cyano group.
19. A compound according to claim 13 , wherein R 5 represents a group —COOR 7 , a monocyclic or polycyclic aryl or a monocyclic or polycyclic heteroaryl group, wherein the monocyclic or polycyclic aryl or the monocyclic or polycyclic heteroaryl group are optionally substituted by one or more substituents chosen from:
halogen atoms;
alkyl groups, which are optionally substituted by one or more substituents chosen from halogen atoms, hydroxyl and alkoxy groups; and
alkoxy, alkoxycarbonyl and hydroxycarbonyl groups;
wherein R 7 represents
an alkyl group, which is optionally substituted by one or more substituents chosen from halogen atoms, hydroxyl and alkoxy groups
or a group of formula
—(CH 2 ) n —R 6
wherein n is an integer from 0 to 4 and R 6 represents:
a cycloalkyl or cycloalkenyl group;
an aryl group, which is optionally substituted by one or more substituents chosen from halogen atoms, alkyl, hydroxy, alkoxy, alkylenedioxy, alkylthio, amino, mono- and di-alkylamino, nitro, acyl, hydroxycarbonyl, alkoxycarbonyl, carbamoyl, mono- and di-alkylcarbamoyl, cyano, trifluoromethyl, difluoromethoxy and trifluoromethoxy groups;
or a 3- to 7-membered ring comprising from 1 to 4 heteroatoms chosen from nitrogen, oxygen and sulphur, which ring is optionally substituted by one or more substituents chosen from halogen atoms, alkyl, phenyl, hydroxy, alkoxy, alkylenedioxy, amino, mono- and di-alkylamino, nitro, cyano and trifluoromethyl groups.
20. A compound according to claim 19 , wherein R 5 represents a monocyclic or polycyclic aryl or a monocyclic or polycyclic heteroaryl group, wherein the monocyclic or polycyclic aryl or the monocyclic or polycyclic heteroaryl group are optionally substituted by one or more substituents chosen from:
halogen atoms;
alkyl groups, which are optionally substituted by one or more substituents chosen from halogen atoms, hydroxyl and alkoxy groups; and
alkoxy groups.
21. A compound according to claim 20 , wherein R 5 represents a monocyclic aryl or heteroaryl group, which is optionally substituted by one or more substituents chosen from halogen atoms and alkyl groups.
22. A compound according to claim 1 , wherein R 1 represents an alkyl group, R 2 represents a hydrogen atom or a group chosen from acyl, alkyl, aryl and heteroaryl groups, wherein the acyl, alkyl, aryl and heteroaryl groups are optionally substituted by one or more halogen atoms, R 3 represents a monocyclic or polycyclic aryl or a monocyclic or polycyclic heteroaryl group, wherein the monocyclic or polycyclic aryl or the monocyclic or polycyclic heteroaryl group are optionally substituted by one or more substituents chosen from halogen atoms, cyano, hydroxycarbonyl and alkyl groups, which are optionally substituted by one or more hydroxy groups, R 4 represents a hydrogen atom, a cyano group, an alkyl or alkenyl group, wherein the alkyl or alkenyl groups are optionally substituted by one substituent chosen from hydroxyl and alkoxy groups or R 4 represents a group of formula (—R 6 ) wherein R 6 represents a 4- to 6-membered ring comprising from 1 to 3 heteroatoms chosen from nitrogen, oxygen and sulphur, which ring is optionally substituted by one substituent chosen from alkyl and phenyl groups and R 5 represents a monocyclic aryl or monocyclic heteroaryl group, wherein the monocyclic aryl or the monocyclic heteroaryl group are optionally substituted by one substituent chosen from halogen atoms, alkyl and alkoxy groups.
23. A compound according to claim 1 , wherein R 1 is chosen from unsubstituted C 1-4 alkyl groups; R 2 is a hydrogen atom; R 3 represents a phenyl group or a monocyclic or polycyclic N-containing heteroaryl group, wherein the phenyl group or the monocyclic or polycyclic N-containing heteroaryl group may be substituted by one substituent chosen from halogen atoms, alkyl groups and hydroxycarbonyl groups; R 4 represents a hydrogen atom or a cyano group and R 5 represents a monocyclic aryl or monocyclic heteroaryl group, wherein the monocyclic aryl or the monocyclic heteroaryl group are optionally substituted by one or more substituents chosen from halogen atoms and alkyl groups.
24. A compound according to claim 1 , chosen from:
4-[(3-chlorophenyl)amino]-2-ethyl-5-(1-hydroxyethyl)-6-phenylpyridazin-3(2H)-one
4-[(3-chlorophenyl )amino]-2-ethyl-5-(1-methoxyethyl)-6-phenylpyridazin-3(2H)-one
4-[(3-chlorophenyl)amino]-2-ethyl-6-phenyl-5-vinylpyridazin-3(2H)-one
4-anilino-2,5-diethyl-6-phenylpyridazin-3(2H)-one
5-[(3-chlorophenyl)amino]-1-ethyl-6-oxo-3-phenyl-1,6-dihydropyridazine-4-carbaldehyde O-methyloxime
5-[(3-chlorophenyl)amino]-1-ethyl-6-oxo-3-phenyl-1,6-dihydropyridazine-4-carbonitrile
1-ethyl-5-{[4-(hydroxymethyl)phenyl]amino}-6-oxo-3-phenyl-1,6-dihydropyridazine-4-carbonitrile
1-ethyl-6-oxo-3-phenyl-5-[(3,4,5-trifluorophenyl)amino]-1,6-dihydropyridazine-4-carbonitrile
5-[(4-cyanophenyl)amino]-1-ethyl-6-oxo-3-phenyl-1,6-dihydropyridazine-4-carbonitrile
1-ethyl-3-(4-fluorophenyl)-5-{[4-(hydroxymethyl)phenyl]amino}-6-oxo-1,6-dihydropyridazine-4-carbonitrile
5-[(4-cyanophenyl)amino]-1-ethyl-3-(4-fluorophenyl)-6-oxo-1,6-dihydropyridazine-4-carbonitrile
1-ethyl-3-(4-fluorophenyl)-6-oxo-5-[(3,4,5-trifluorophenyl)amino]-1,6-dihydropyridazine-4-carbonitrile
1-ethyl-3-(4-fluorophenyl)-6-oxo-5-(pyridin-3-ylamino)-1,6-dihydropyridazine-4-carbonitrile
1-ethyl-3-(3-fluorophenyl)-5-{[4-(hydroxymethyl)phenyl]amino}-6-oxo-1,6-dihydropyridazine-4-carbonitrile
5-[(4-cyanophenyl)amino]-1-ethyl-3-(3-fluorophenyl)-6-oxo-1,6-dihydropyridazine-4-carbonitrile
1-ethyl-3-(3-fluorophenyl)-6-oxo-5-[(3,4,5-trifluorophenyl)amino]-1,6-dihydropyridazine-4-carbonitrile
4-[(3-chlorophenyl)amino]-2-ethyl-5-(2-methyl-1,3-thiazol-4-yl)-6-phenylpyridazin-3(2H)-one
4-[(3-chlorophenyl)amino]-2-ethyl-6-phenyl-5-(2-phenyl-1,3-thiazol-4-yl)pyridazin-3(2H)-one
4-[(3-chlorophenyl)amino]-2-ethyl-5-(1-methyl-1H-pyrazol-5-yl)-6-phenylpyddazin-3(2H)-one
4-{[2-ethyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)-3-oxo-6-phenyl-2,3-dlhydropyridazin-4-yl]amino}benzonltrile
2-ethyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)-6-phenyl-4-[(3,4,5-trifluorophenyl) amino]pyridazin-3(2H)-one
4-[(3-chlorophenyl)amino]-2-ethyl-6-phenylpyridazin-3(2H)-one
2-ethyl-4-[(3-fluorophenyl)amino]-6-phenylpyridazin-3(2H)-one
2-ethyl-4-(1-naphthylamino)-6-phenylpyridazin-3(2H)-one
2-ethyl-6-phenyl-4-(pyridin-3-ylamino)pyridazin-3(2H)-one
2-ethyl-6-phenyl-4-(quinolin-5-ylamino)pyridazin-3(2H)-one
4-(diquinolin-5-ylamino)-2-ethyl-6-phenylpyridazin-3(2H)-one
4-[bis(3,4,5-trifluorophenyl)amino]-2-ethyl-6-phenylpyridazin-3(2H)-one
4-[bis(3,4-difluorophenyl)amino]-2-ethyl-6-phenylpyridazin-3(2H)-one
4-[(3,4-difluorophenyl)amino]-2-ethyl-6-phenylpyridazin-3(2H)-one
4-[(3-chloro-4-fluorophenyl)amino]-2-ethyl-6-phenylpyridazin-3(2H)-one
4-[(2-ethyl-3-oxo-6-phenyl-2,3-dihydropyridazin-4-yl)amino]benzonitrile
2-ethyl-4-[(1-oxidopyridin-3-yl)amino]-6-phenylpyridazin-3(2H)-one
2-ethyl-6-pyridin-3-yl-4-(pyridin-3-ylamino)pyridazin-3(2H)-one
2-ethyl-4-[(1-oxidoquinolin-5-yl)amino]-6-phenylpyridazin-3(2H)-one
2-ethyl-6-pyridin-4-yl-4-(pyridin-3-ylamino)pyridazin-3(2H)-one
2-ethyl-4-(isoquinolin-4-ylamino)-6-phenylpyridazin-3(2H)-one
2-ethyl-6-phenyl-4-[(3,4,5-trifluorophenyl)amino]pyridazin-3(2H)-one
2-ethyl-4-[(4-fluorophenyl)amina]-6-phenylpyridazin-3(2H)-one
2-ethyl-6-pyridin-3-yl-4-(quinolin-5-ylamino)pyridazin-3(2H)-one
2-methyl-6-pyridin-3-yl-4-(quinolin-5-ylamino)pyridazin-3(2H)-one
2-ethyl-6-pyridin-4-yl-4-(quinolin-5-ylamino)pyridazin-3(2H)-one
2-ethyl-4-{[4-(hydroxymethyl)phenyl]amino}-6-phenylpyridazin-3(2H)-one
4-[(2-methyl-3-oxo-6-pyridin-3-yl-2,3-dihydropyridazin-4-yl)amino]benzonitrile
4-[(2-ethyl-3-oxo-6-pyridin-3-yl-2,3-dihydropyridazin-4-yl)amino]benzonitrile methyl 4-[(2-ethyl-3-oxo-6-phenyl-2,3-dihydropyridazin-4-yl)amino]benzoate
4-{[2-ethyl-6-(1-oxidopyridin-3-yl)-3-oxo-2,3-dihydropyridazin-4-yl]amino}benzonitrile
2-ethyl-4-(isoquinolin-4-ylamino)-6-pyridin-3-ylpyridazin-3(2H)-one
2-ethyl-4-[(4-methylpyridin-3-yl)amino]-6-pyridin-3-ylpyridazin-3(2H)-one
2-ethyl-4-(isoquinolin-4-ylamino)-6-pyridin-4-ylpyridazin-3(2H)-one
4-[(2-ethyl-3-oxo-6phenyl-2,3-dihydropyridazin-4-yl)amino]benzoic acid
2-ethyl-4-[(4-methylpyridin-3-yl)amino]-6-pyridin-4-ylpyridazin-3(2H)-one
4-[(2-ethyl-3-oxo-6-pyridin-4-yl-2,3-dihydropyridazin-4-yl)amino]benzonitrile
4-[(2-ethyl-3-oxo-6-phenyl-2,3-dihydropyridazin-4-yl)(methyl)amino]benzonitrile N-(4-cyanophenyl)-N-(2-ethyl-3-oxo-6-phenyl-2,3-dihydropyridazin-4-yl)acetamide
6-(3-chlorophenyl)-2-ethyl-4-(pyridin-3-ylamino)pyridazin-3(2H)-one
2-ethyl-4-[methyl(quinolin-5-yl)amino]-6-phenylpyridazin-3(2H)-one
6-(3-chlorophenyl)-2-ethyl-4-(isoquinolin-4-ylamino)pyridazin-3(2H)-one
N-(2-ethyl-3-oxo-6-phenyl-2,3-dihydropyridazin-4-yl)-N-quinolin-5-yl)acetamide
2-Ethyl-4-(4-hydroxymethyl-phenylamino)-6-pyridin-3-ylpyridazin-3(2H)-one
2-ethyl-4-(isoquinolin-4-ylamino)6-(4-methoxyphenyl)pyridazin-3(2H)-one
2-ethyl-6-(4-methoxyphenyl)-4-(quinolin-5-ylamino)pyridazin-3(2H)-one
4-anilino-2-ethyl-6-phenylpyridazin-3(2H)-one
2-ethyl-6-(4-methylphenyl)-4-(quinolin-5-ylamino)pyridazin-3(2H)-one
2-ethyl-6-(4-methylphenyl)-4-[(1-oxidoquinolin-5-yl)amino]pyridazin-3(2H)-one
2-Ethyl-6-phenyl-4-(thieno[2,3-c]pyridin-3-ylamino)pyridazin-3(2H)-one
1-Ethyl-6-oxo-3-phenyl-5-(pyridin-3-ylamino)-1,6-dihydropyridazine-4-carbonitrile
1-Ethyl-3-(3-methylphenyl)-6-oxo-5-(pyridin-3-ylamino)-1,6-dihydropyridazine-4-carbonitrile
2-Ethyl-5-(1-hydroxyethyl)-6-phenyl-4-(quinolin-5-ylamino)pyridazin-3(2H)-one
2-Ethyl-6-(4-methylphenyl)-4-(pyridin-3-ylamino)pyridazin-3(2H)-one
2-Ethyl-4-(isoquinolin-4-ylamino)-6-(4-methylphenyl)pyridazin-3(2H)-one
2-Ethyl-6-(4-methylphenyl)-4-[(4-methylpyridin-3-yl)amino]pyridazin-3(2H)-one
2-Ethyl-6-(3-methylphenyl)-4-(pyridin-3-ylamino)pyridazin-3(2H )-one
2-Ethyl-4-(isoquinolin-4-ylamino)-6-(3-methylphenyl)pyridazin-3(2H)-one
2-Ethyl-6-(3-methylphenyl)-4-[(4-methylpyridin-3-yl)amino]pyridazin-3(2H)-one
4-{[2-Ethyl-6-(3-methylphenyl)-3-oxo-2,3-dihydropyridazin-4-yl]amino}benzoic acid
2-Ethyl-6-(5-methylpyridin-3-yl)-4-(pyridin-3-ylamino)pyridazin-3(2H)-one
2-Ethyl-4-(isoquinolin-4-ylamino)-6-(5-methylpyridin-3-yl)pyridazin-3(2H)-one
2-Ethyl-6-(5-methylpyridin-3-yl)-4-[(4-methylpyridin-3-yl)amino]pyridazin-3(2H)-one
2-Ethyl-4-(1,7-naphthyridin-5-ylamino)-6-phenylpyridazin-3(2H)-one
[1-Ethyl-6-oxo-3-phenyl-5-(pyridin-3-ylamino)-1,6-dihydropyridazin-4-yl]methyl acetate
[1-Ethyl-6-oxo-3-phenyl-5-(pyridin-3-ylamino)-1,6-dihydropyridazin-4-yl]methyl butyrate
2-Ethyl-5-[2-(4-methoxyphenyl)-1,3-thiazol-4-yl]-6-phenyl-4-(pyridin-3-ylamino) pyridazin-3(2H)-one
2-Ethyl-4-(isoquinolin-4-ylamino)-6-(6-methylpyridin-3-yl)pyridazin-3(2H)-one
2-Ethyl-6-(6-methylpyridin-3-yl)-4-(pyridin-3-ylamino)pyridazin-3(2H)-one
2-Ethyl-5-[2-(4-methoxyphenyl)-1,3-thiazol-4-yl]-4-[(4-methylpyridin-3-yl)amino]-6-phenylpyridazin-3(2H)-one
2-Ethyl-6-phenyl-4-(pyridin-3-ylamino)-5-(2-pyridin-4-yl-1,3-thiazol-4-yl)pyridazin-3(2H)-one
Ethyl 4-[1-ethyl-6-oxo-3-phenyl-5-(pyridin-3-ylamino)-1,6-dihydropyridazin-4-yl]-1,3-thiazole-2-carboxylate
2-Ethyl-4-(isoquinolin-4-ylamino)-5-[2-(4-methoxyphenyl)-1,3-thiazol-4-yl]-6-phenylpyridazin-3(2H)-one
2-Ethyl-4-[(4-methylpyridin-3-yl)amino]-6-phenyl-5-(2-pyridin-4-yl-1,3-thiazol-4-yl) pyridazin-3(2H)-one
5-[2-(4-Chlorophenyl)-1,3-thiazol-4-yl]-2-ethyl-4-[(4-methylpyridin-3-yl)amino]-6-phenylpyridazin-3(2H)-one
5-[2-(4-Chlorophenyl)-1,3-thiazol-4-yl]-2-ethyl-6-phenyl-4-(pyridin-3-ylamino)pyridazin-3(2H)-one
5-[2-(4-Chlorophenyl)-1,3-thiazol-4-yl]-2-ethyl-4-(isoquinolin-4-ylamino)-6-phenylpyridazin-3(2H)-one
2-Ethyl-4-[(4-methylpyridin-3-yl)amino]-6-phenylpyridazin-3(2H)-one
2-Ethyl-4-[(4-methyl-1-oxidopyridin-3-yl)amino]-6-phenylpyridazin-3(2H)-one
Ethyl 4-[(2-ethyl-3-oxo-6-phenyl-2,3-dihydropyridazin-4-yl)amino]benzoate.
or a pharmaceutically acceptable salt thereof.
25. A pharmaceutical composition, comprising a compound according to claim 1 and a pharmaceutically acceptable diluent or carrier.
26. A method for treating a subject afflicted with a pathological condition or disease susceptible to amelioration by inhibition of phosphodiesterase 4, comprising administering to said subject an effective amount of a compound according to claim 1 , wherein the pathological condition or disease is chosen from asthma, atopic dermatitis and psoriasis.
27. A combination product comprising:
(i) a compound according to claim 1 ; and
(ii) another compound chosen from (a) steroids, (b) immunosuppressive agents, (c) T-cell receptor blockers and (d) antiinflammatory drugs.
28. A method for treating a subject afflicted with a pathological condition or disease susceptible to amelioration by inhibition of phosphodiesterase 4, comprising administering to said subject an effective amount of a compound according to claim 1 , and further comprising the simultaneous, separate or sequential administration to said subject of another compound chosen from (a) steroids, (b) immunosuppressive agents, (c) T-cell receptor blockers and (d) antiinflammatory drugs, wherein the pathological condition or disease is chosen from asthma, atopic dermatitis and psoriasis.